JG
Jain Global Portfolio holdings
AUM
$6.43B
This Quarter Return
+5.92%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$6.43B
AUM Growth
+$1.54B
(+32%)
Cap. Flow
+$884M
Cap. Flow
% of AUM
13.74%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
1,650
New
616
Increased
267
Reduced
163
Closed
560
Top Buys
| 1 |
Brown & Brown
BRO
|
+$111M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$80.4M |
| 3 |
American Tower
AMT
|
+$76.2M |
| 4 |
Ecolab
ECL
|
+$75.4M |
| 5 |
Tesla
TSLA
|
+$73.2M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.3B |
| 2 |
NVIDIA
NVDA
|
+$73.4M |
| 3 |
Microsoft
MSFT
|
+$55.5M |
| 4 |
PPG Industries
PPG
|
+$47.7M |
| 5 |
Boeing
BA
|
+$45.7M |
Sector Composition
| 1 | Technology | 18.36% |
| 2 | Industrials | 13.55% |
| 3 | Consumer Discretionary | 11.92% |
| 4 | Financials | 10.86% |
| 5 | Healthcare | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
NN Inc
NNBR
$126M
| $92.9K | ﹤0.01% |
+44,219
| New | +$92.9K |
|
952
TTEC Holdings
TTEC
$183M
| $92.7K | ﹤0.01% |
19,272
+6,484
| +51% | +$31.2K |
|
953
Berry Corp
BRY
$248M
| $92.5K | ﹤0.01% |
+33,395
| New | +$92.5K |
|
954
Xponential Fitness
XPOF
$305M
| $92.1K | ﹤0.01% |
+12,295
| New | +$92.1K |
|
955
Twin Disc
TWIN
$189M
| $90.6K | ﹤0.01% |
+10,266
| New | +$90.6K |
|
956
Blend Labs
BLND
$1.13B
| $90.4K | ﹤0.01% |
+27,395
| New | +$90.4K |
|
957
Virgin Galactic
SPCE
$183M
| $90.3K | ﹤0.01% |
33,091
-25,358
| -43% | -$69.2K |
|
958
SFL Corp
SFL
$1.1B
| $90K | ﹤0.01% |
+10,800
| New | +$90K |
|
959
Bumble
BMBL
$703M
| $87.8K | ﹤0.01% |
13,325
-91,796
| -87% | -$605K |
|
960
Achieve Life Sciences
ACHV
$159M
| $87.7K | ﹤0.01% |
+38,806
| New | +$87.7K |
|
961
Neumora Therapeutics
NMRA
$269M
| $86.9K | ﹤0.01% |
118,493
+65,106
| +122% | +$47.7K |
|
962
Claros Mortgage Trust
CMTG
$537M
| $86K | ﹤0.01% |
+30,170
| New | +$86K |
|
963
Cabaletta Bio
CABA
$150M
| $85.4K | ﹤0.01% |
+56,160
| New | +$85.4K |
|
964
Corbus Pharmaceuticals
CRBP
$121M
| $85.3K | ﹤0.01% |
+12,369
| New | +$85.3K |
|
965
Cassava Sciences
SAVA
$105M
| $84.8K | ﹤0.01% |
+46,842
| New | +$84.8K |
|
966
Leslie's
LESL
$62.6M
| $84.4K | ﹤0.01% |
201,034
+131,439
| +189% | +$55.2K |
|
967
QuickLogic
QUIK
$83.3M
| $84K | ﹤0.01% |
+13,642
| New | +$84K |
|
968
Zentalis Pharmaceuticals
ZNTL
$118M
| $83.8K | ﹤0.01% |
+72,261
| New | +$83.8K |
|
969
Skye Bioscience
SKYE
$128M
| $83K | ﹤0.01% |
+19,852
| New | +$83K |
|
970
Zynex
ZYXI
$44.2M
| $80.7K | ﹤0.01% |
+31,295
| New | +$80.7K |
|
971
Kyverna Therapeutics
KYTX
$169M
| $80.6K | ﹤0.01% |
+26,243
| New | +$80.6K |
|
972
Eventbrite
EB
$264M
| $80.1K | ﹤0.01% |
+30,458
| New | +$80.1K |
|
|
CTNM
973
Contineum Therapeutics
CTNM
$340M
| $77.8K | ﹤0.01% |
+19,590
| New | +$77.8K |
|
974
Veru
VERU
$49.4M
| $76.6K | ﹤0.01% |
+13,161
| New | +$76.6K |
|
975
Inovio Pharmaceuticals
INO
$146M
| $76.5K | ﹤0.01% |
+37,601
| New | +$76.5K |
|